JP2024543345A5 - - Google Patents
Info
- Publication number
- JP2024543345A5 JP2024543345A5 JP2024526836A JP2024526836A JP2024543345A5 JP 2024543345 A5 JP2024543345 A5 JP 2024543345A5 JP 2024526836 A JP2024526836 A JP 2024526836A JP 2024526836 A JP2024526836 A JP 2024526836A JP 2024543345 A5 JP2024543345 A5 JP 2024543345A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- week
- subject
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163280069P | 2021-11-16 | 2021-11-16 | |
| US63/280,069 | 2021-11-16 | ||
| US202263357240P | 2022-06-30 | 2022-06-30 | |
| US63/357,240 | 2022-06-30 | ||
| PCT/US2022/049969 WO2023091414A1 (en) | 2021-11-16 | 2022-11-15 | Compounds for treating mds-associated anemias and other conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543345A JP2024543345A (ja) | 2024-11-21 |
| JP2024543345A5 true JP2024543345A5 (https=) | 2025-11-26 |
Family
ID=84887868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526836A Pending JP2024543345A (ja) | 2021-11-16 | 2022-11-15 | Ｍｄｓ関連貧血及び他の状態を処置するための化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250108049A1 (https=) |
| EP (1) | EP4433057A1 (https=) |
| JP (1) | JP2024543345A (https=) |
| KR (1) | KR20240107326A (https=) |
| AU (1) | AU2022390088A1 (https=) |
| CA (1) | CA3236880A1 (https=) |
| CL (1) | CL2024001431A1 (https=) |
| IL (1) | IL312679A (https=) |
| MX (1) | MX2024005852A (https=) |
| TW (1) | TW202329935A (https=) |
| WO (1) | WO2023091414A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202509043A (zh) * | 2023-05-15 | 2025-03-01 | 美商阿吉歐斯製藥公司 | ２－（（１ｈ－吡唑－３－基）甲基）－６－（（６－胺基吡啶－２－基）甲基）－４－甲基－４，６－二氫－５ｈ－噻唑基［５＇，４＇：４，５］吡咯并［２，３－ｄ］嗒𠯤－５－酮之結晶形式 |
| WO2026076363A1 (en) | 2024-10-04 | 2026-04-09 | Agios Pharmaceuticals, Inc. | Compounds for treating mds-associated anemias and other conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI598337B (zh) | 2009-06-29 | 2017-09-11 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| CA2989111C (en) | 2015-06-11 | 2023-10-03 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| TWI796353B (zh) | 2017-08-15 | 2023-03-21 | 美商阿吉歐斯製藥公司 | 丙酮酸激酶調節劑及其用途 |
| KR102777452B1 (ko) | 2017-11-22 | 2025-03-10 | 아지오스 파마슈티컬스 아이엔씨. | N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의결정 형태 |
| WO2020237047A1 (en) | 2019-05-22 | 2020-11-26 | Agios Pharmaceuticals, Inc. | Crystalline salt forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide |
-
2022
- 2022-11-15 IL IL312679A patent/IL312679A/en unknown
- 2022-11-15 EP EP22839539.8A patent/EP4433057A1/en active Pending
- 2022-11-15 JP JP2024526836A patent/JP2024543345A/ja active Pending
- 2022-11-15 MX MX2024005852A patent/MX2024005852A/es unknown
- 2022-11-15 CA CA3236880A patent/CA3236880A1/en active Pending
- 2022-11-15 AU AU2022390088A patent/AU2022390088A1/en active Pending
- 2022-11-15 TW TW111143555A patent/TW202329935A/zh unknown
- 2022-11-15 WO PCT/US2022/049969 patent/WO2023091414A1/en not_active Ceased
- 2022-11-15 US US18/711,090 patent/US20250108049A1/en active Pending
- 2022-11-15 KR KR1020247019391A patent/KR20240107326A/ko active Pending
-
2024
- 2024-05-14 CL CL2024001431A patent/CL2024001431A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1111414C (zh) | 镁盐或镁配合物的制药用途 | |
| JP2024543345A5 (https=) | ||
| JP2024528127A5 (https=) | ||
| WO2022218958A1 (en) | Combination comprising everolimus and amcenestrant | |
| JP2001520656A (ja) | 抗腫瘍剤としてのホルボールエステル類 | |
| JP2022521233A5 (https=) | ||
| CN113842449B (zh) | 枸杞糖肽在制备预防和/或治疗肌萎缩侧索硬化的药物中的应用 | |
| JP2024536126A5 (https=) | ||
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| JP2023553253A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| WO2018214860A1 (zh) | 治疗再生障碍性贫血的方法和药物组合物 | |
| TWI760306B (zh) | 供治療癌症之口服投予紫杉醇及Ｐ-ｇｐ抑制劑的治療性組合 | |
| JPH08512311A (ja) | 慢性疲労症候群治療用ヒ素医薬 | |
| JP2023520703A5 (https=) | ||
| JP7505160B2 (ja) | ヒドロキシ尿素を含む炎症反応を阻害するための医薬組成物 | |
| JP2024545496A5 (https=) | ||
| JPWO2022265031A5 (https=) | ||
| US4814336A (en) | Method of treating a vascular obstructive lesion resulting from restricted blood circulation | |
| JP3253878B2 (ja) | 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法 | |
| JP2025505578A5 (https=) | ||
| JP2024523406A5 (https=) | ||
| CN117224514B (zh) | 一种化合物、组合物及其在制备治疗心律失常的药物中的应用 | |
| US6355682B1 (en) | Treatment of acute renal failure by administration of N-acetylcysteine | |
| CN114887063A (zh) | Pacsin1在抑制瑞芬太尼诱发的痛觉过敏中的应用 |